Where is the Outrage? FDA approves OxyContin for children and I warned you in 2009 and 2011!
Have you seen the statistics in Florida of the deaths and addictions to controlled substances?
Marianne Skolek Global News Centre
(MYRTLE BEACH) In April 2011, I wrote an article for Salem-News.com (shown below in its entirety with comments from contributors to OxyContin being prescribed to children as guinea pigs). Today, the FDA announced that Purdue Pharma, maker of OxyContin has been given the green light to prescribe the killer drug to children. The news has caused a frenzy of outrage from organizations and individuals fighting the prescription opioid epidemic in the U.S. and Canada. So how did this happen and what will the result of this FDA approval be in an out of control prescription opioid/heroin epidemic? Where is your outrage and what will you do about it?
Kids: the New Guinea Pigs for Oxycontin Maker Purdue Pharma
Courtesy: hubpages.com
|
Ages Eligible for Study: | 6 Years to 16 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
- Male and female patients aged 6 to 16 years, inclusive, who are expected to require ongoing around-the-clock opioid treatment equivalent to at least 20-mg daily dose of oxycodone for at least 2 weeks for management of moderate to severe (based on the investigator’s judgment) malignant or nonmalignant pain.
- Patients must be opioid tolerant, ie, have been treated with opioids for at least the 5 consecutive days prior to dosing and with at least 20 mg daily of oxycodone or the equivalent during at least the last 48 hours prior to the start of study drug dosing and have tolerated the therapy, as demonstrated at the start of study drug dosing.
- Patients who are currently using transdermal fentanyl should have been on the patch for at least 3 days before removing the patch and oxycodone hydrochloride (HCl) controlled-release (CR) treatment can only be initiated at least 18 hours following the removal of the transdermal fentanyl patch.
- Patients must not require more than a 240-mg total daily dose of oxycodone HCl CR tablets.
- Patients must be willing and able to swallow the oxycodone HCl CR tablets whole.
- Patients must not be currently on an investigational medication/therapy at the start of screening or during the study.
- Female patients who are pregnant or lactating.
- Patients who are allergic to oxycodone or have a history of allergies to other opioids (this criterion does not include patients who have experienced common opioid side effects [eg, nausea, constipation]).
- Patients who have received epidural opioids < 2 hours prior to the first dose of study drug or who have received epidural morphine < 12 hours prior to the first dose of study drug.
- Patients who are contraindicated for the use of opioids.
- Patients who are contraindicated for blood sampling.
- Patients who are currently being maintained on methadone for pain.
- Patients who have any planned surgery during the course of the study, with the exception of the placement of central or peripheral venous access devices.
- Patients who have had surgery within 120 hours prior to Day 1 (day of first dose of study drug).
Contact: Deborah Steiner, MD | 203-588-7413 | [email protected] |
United States, Arizona | |
Maricopa Medical Center | Recruiting |
Phoenix, Arizona, United States, 85008 | |
Contact: David Rosenberg, MD | |
Principal Investigator: David Rosenberg, MD | |
United States, California | |
Loma Linda University Medical Center | Recruiting |
Loma Linda, California, United States, 92354 | |
Contact: Peter Przekop, MD | |
Principal Investigator: Peter Przekop, MD | |
LS Packard Children’s Hospital | Recruiting |
Palo Alto, California, United States, 94304 | |
Contact: Elliot Krane, MD | |
Principal Investigator: Elliot Krane, MD | |
Bayview Research Group, LLC | Recruiting |
Paramount, California, United States, 90723 | |
Contact: Mohammad Riaz, MD | |
Principal Investigator: Mohammad Riaz, MD | |
United States, Colorado | |
The Children’s Hospital | Recruiting |
Aurora, Colorado, United States, 80045 | |
Contact: Jeffrey Galinkin, MD | |
Principal Investigator: Jeffrey Galinkin, MD | |
United States, Pennsylvania | |
Penn State Hershey Children’s Hospital | Recruiting |
Hershey, Pennsylvania, United States, 17033 | |
Contact: Andrew S. Freiberg, MD | |
Principal Investigator: Andrew S. Freiberg, MD | |
United States, Texas | |
Children’s Medical Ctr of Dallas | Recruiting |
Dallas, Texas, United States, 75235 | |
Contact: Peter Szmuk, MD | |
Principal Investigator: Peter Szmuk, MD | |
Estonia | |
Tallinn Children’s Hospital | Recruiting |
Tallinn, Estonia, 13419 | |
Contact: Kadri Saks, MD | |
Principal Investigator: Kadri Saks, MD | |
Tartu University Hospital | Recruiting |
Tartu, Estonia, 51014 | |
Contact: Karin Varik, MD, Ph.D. | |
Principal Investigator: Karin Varik, MD, Ph.D. |
Responsible Party: | Purdue Pharma LP ( Medical Monitor ) |
ClinicalTrials.gov Identifier: | NCT01192295 History of Changes |
Other Study ID Numbers: | OTR3001, 2010-020471-23 |
Study First Received: | August 30, 2010 |
Last Updated: | March 28, 2011 |
Health Authority: | United States: Food and Drug Administration; Estonia: State Agency of Medicines |
Malignant pain Nonmalignant pain Pediatric Opioid Moderate to severe malignant or nonmalignant pain |
Oxycodone Analgesics, Opioid Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs |
Pharmacologic Actions Central Nervous System Agents Therapeutic Uses Central Nervous System Depressants Narcotics |
__________________________________________________________
Global News Centre’s Marianne Skolek, is an Investigative Reporter who focuses on the Prescription Opioid/Heroin Epidemic in the U.S. and Canada. In particular, Marianne has covered the criminal marketing of OxyContin going back to 1999 and continuing to the present.
In 2002, Marianne lost her daughter, Jill to prescribed OxyContin which her physician referred to as “mobility in a bottle.” It was, in fact, death in a bottle. After doing extensive research on the maker of OxyContin, Purdue Pharma, Marianne began working with the Department of Justice in Virginia in their criminal investigation into Purdue Pharma and in July 2007 was asked by the U.S. Attorney John Brownlee prosecuting the case to testify against the three CEO’s of Purdue Pharma, Michael Friedman, Paul Goldenheim, MD and Howard Udell, Chief Counsel. The CEO’s pleaded guilty to misleading the medical profession about the dangers of OxyContin. Marianne also testified against Purdue Pharma at a Judiciary Hearing of the U.S. Senate in July 2007.
In addition, a dangerous and highly addictive opioid named Zohydro has been approved by the FDA against their Advisory Committee’s advice and Marianne continues to alert Attorneys General, Senators and Congressmen as to the FDA’s irresponsibility in the out of control prescription opioid/heroin epidemic killing and addicting in the tens of thousands each year. Zohydro has been referred to as “heroin in a capsule” and its lowest dosage (10mg) contains twice as much hydrocodone as found in a Vicodin pill. The highest single dose of Zohydro contains as much hydrocodone as 5 to 10 tablets of Vicodin or Lortab. Zohydro mixed with alcohol can be fatal and has no abuse deterrent built in which will make it easy to crush and deliver a fatal dose of the opioid.
Currently Marianne has been instrumental in calling for the termination of Margaret Hamburg, MD, Commissioner of the FDA as well as Bob A. Rappaport, MD and Douglas Throckmorton, MD for their lack of commitment to safeguarding the American public against the prescription opioid/heroin epidemic. Marianne’s research, writing and contact with government agencies and attorneys has also exposed the heavily funded pain foundations set up by the pharmaceutical industry and their paid physician spokespersons who convinced the medical boards in 50 states and Canada that dangerous opioids such as OxyContin were less likely to be addictive. These physicians — in particular Scott Fishman, MD, J. David Haddox, DDS, MD, Perry Fine, MD, Lynn R. Webster, MD, Russell Portenoy, MD also downplayed the risks of addictive opioids in books as authors. These books are still available for sale and promoted to the medical profession.
Here are links to Marianne’s involvement in exposing the national conspiracy of the prescription opioid/heroin epidemic, the FDA, the pharmaceutical industry, their pain foundations and paid physician spokespersons.
http://www.salem-news.com/by_author.php?reporter=Marianne%20Skolek
http://www.youtube.com/watch?v=tmPG1VjD61U&list=UUWoHUEr4ZAbQOfIqtOArjgg&index=6&feature=plcp
https://www.facebook.com/photo.php?v=855537227796352&set=vb.658186307531446&type=2&theater
- See more at: http://www.globalnewscentre.com/2014/06/06/no-accountability-in-the-opioidheroin-epidemic-results-in-dangerous-false-prophets/#sthash.mMTdZITB.dpuf
- See more at: http://www.globalnewscentre.com/2014/06/06/no-accountability-in-the-opioidheroin-epidemic-results-in-dangerous-false-prophets/#sthash.mMTdZITB.dpuf
- See more at: http://www.globalnewscentre.com/2014/06/06/no-accountability-in-the-opioidheroin-epidemic-results-in-dangerous-false-prophets/#sthash.mMTdZITB.dpuf
- See more at: http://www.globalnewscentre.com/2014/06/06/no-accountability-in-the-opioidheroin-epidemic-results-in-dangerous-false-prophets/#sthash.mMTdZITB.dpuf
Leave a Reply
You must be logged in to post a comment.
Megan Steiner April 30, 2011 3:07 am (Pacific time)
My mother is no Dr. Mengele, Miss Skolek. She is a doctor who believes in helping children, not tricking them. Many drugs can be abused, and many drug companies produce such drugs. I am sorry for your daughter’s fate, but for every girl like your daughter, there is a girl like me. And as you fight for children like your daughter, protecting them from pharmaceutical companies, my mother stands by me and those like me every day, hoping to help build us a better, pain-free future.
Perhaps, Miss Skolek, when you next choose vilify some MD, you will take a moment to consider that, perhaps, behind that MD is a good person with a loving family.Sincerely,
Megan Steiner, or as I may now call myself, [“Steiner the Protector” of my mom”]
curtis April 26, 2011 4:30 pm (Pacific time)
G April 24, 2011 5:52 pm (Pacific time)
Sarah_H April 24, 2011 5:09 pm (Pacific time)